Advisor Group Inc. Buys 8,884 Shares of Theralase Technologies Inc. (TLT)

Advisor Group Inc. raised its stake in shares of Theralase Technologies Inc. (NASDAQ:TLT) by 13.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 76,612 shares of the company’s stock after purchasing an additional 8,884 shares during the period. Advisor Group Inc. owned 0.12% of Theralase Technologies worth $9,558,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in TLT. Alleghany Corp DE bought a new stake in Theralase Technologies during the third quarter valued at about $449,136,000. Ameriprise Financial Inc. lifted its position in shares of Theralase Technologies by 293.2% in the second quarter. Ameriprise Financial Inc. now owns 2,875,805 shares of the company’s stock valued at $359,568,000 after acquiring an additional 2,144,378 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Theralase Technologies by 837.3% in the second quarter. JPMorgan Chase & Co. now owns 915,494 shares of the company’s stock valued at $114,546,000 after acquiring an additional 817,818 shares in the last quarter. FMR LLC lifted its position in shares of Theralase Technologies by 45.4% in the second quarter. FMR LLC now owns 2,454,499 shares of the company’s stock valued at $307,107,000 after acquiring an additional 766,689 shares in the last quarter. Finally, Bridgewater Associates LP purchased a new position in shares of Theralase Technologies in the second quarter valued at about $92,200,000.

Shares of Theralase Technologies Inc. (NASDAQ:TLT) traded down $1.90 during trading on Monday, hitting $124.10. The stock had a trading volume of 11,980,900 shares, compared to its average volume of 8,343,837. Theralase Technologies Inc. has a fifty-two week low of $116.49 and a fifty-two week high of $129.57.

The firm also recently disclosed a monthly dividend, which was paid on Tuesday, November 7th. Stockholders of record on Thursday, November 2nd were given a $0.2631 dividend. This represents a $3.16 annualized dividend and a dividend yield of 2.54%. This is an increase from Theralase Technologies’s previous monthly dividend of $0.25. The ex-dividend date was Wednesday, November 1st. Theralase Technologies’s payout ratio is presently 17.16%.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another domain, it was copied illegally and republished in violation of US & international trademark and copyright laws. The legal version of this report can be accessed at https://www.chaffeybreeze.com/2017/11/13/advisor-group-inc-buys-8884-shares-of-theralase-technologies-inc-tlt.html.

About Theralase Technologies

iShares 20+ Year Treasury Bond ETF (the Fund) is an exchange-traded fund. The Fund seeks to track the investment results of an index composed of United States Treasury bonds with remaining maturities greater than 20 years. The Fund seeks to track the investment results of the Barclays U.S. 20+ Year Treasury Bond Index (the Underlying Index), which measures the performance of public obligations of the United States Treasury that have a remaining maturity of 20 or more years.

Want to see what other hedge funds are holding TLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Theralase Technologies Inc. (NASDAQ:TLT).

Institutional Ownership by Quarter for Theralase Technologies (NASDAQ:TLT)

Receive News & Ratings for Theralase Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply